Myeloproliferative neoplasm primary prevention: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{MJK}} {{shyam}} | {{CMG}}{{AE}} {{MJK}} {{shyam}} | ||
==Overview== | ==Overview== | ||
There is no established method for primary prevention of myeloproliferative neoplasm. | There is no established method for primary prevention of myeloproliferative neoplasm. | ||
==Primary Prevention== | ==Primary Prevention== | ||
There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> Routine monitoring of the [[complete blood count]] on a yearly basis is sufficient for monitoring. | There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> Routine monitoring of the [[complete blood count]] on a yearly basis is sufficient for monitoring. | ||
Latest revision as of 15:57, 28 June 2018
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm primary prevention On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm primary prevention |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]
Overview
There is no established method for primary prevention of myeloproliferative neoplasm.
Primary Prevention
There is no established method for primary prevention of myeloproliferative neoplasm.[1] Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative